News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–28
Matches
28
Sources here
10
Companies here
1
Search results Stored financial headlines

Active search

28 matching headlines

Ticker or company: ZYBTMain company stories
Clear
Latest

TradingKey Earnings

Zhengye Biotechnology Holding Ltd (ZYBT) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Zhengye Biotechnology Holding Ltd (ZYBT), focusing on future EPS and revenue growth estimates. As of August 8, 2026, ZYBT's stock closed at $1.890 USD, down 9.57%, with a market cap of $89.57 million. The page includes an overview, news, financials, stock score, technical forecast, ownership, and dividend information, alongside a peer …

ZYBT Stock Whipsaws As Speculative Trading Dominates Tape

Zhengye Biotechnology Holding Limited (ZYBT) stock is experiencing extreme volatility due to speculative trading, with large price swings that disconnect from its underlying fundamentals. Despite manageable debt and significant assets, the company shows negative returns on invested capital, indicating it's destroying value. Traders are …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement

Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) announced that it has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share. This comes after its Class A ordinary shares closed at or above $1.00 for 10 consecutive business days from July 20 to …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

ZYBT Stock Whipsaws As Speculative Trading Frenzy Unwinds

Zhengye Biotechnology Holding Limited (ZYBT) stock experienced extreme volatility, whipsawing significantly due to speculative trading. After a massive 1,047% surge, the stock plunged by over 70% and continued to show significant premarket swings, indicating a classic boom-and-bust pattern driven by momentum rather than fundamentals. …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

$Zhengye Biotechnology (ZYBT.US)$ Will there be another miracle?[Grin][Cool Guy]

The article poses a question about whether Zhengye Biotechnology (ZYBT.US) will experience another "miracle." It's a brief post from a user named "活的踏实 活的精彩" within the moomoo Community, indicating a discussion about the stock's future performance. The post itself is minimal, serving primarily as …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Zhengye Biotechnology Company Profile & Introduction

This document appears to be a company profile and introduction for Zhengye Biotechnology. Without further content, a detailed summary is not possible, but it likely outlines the company's operations, mission, and key offerings within the biotechnology sector.

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Zhengye Biotechnology Holding Ltd (ZYBT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Zhengye Biotechnology Holding Ltd (ZYBT), detailing its support, resistance levels, and performance based on various technical indicators and moving averages. According to the analysis, the overall signal for ZYBT is Neutral, with specific indicators showing mixed signals …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Zhengye Biotechnology Holding Ltd (ZYBT) Balance Sheet

This article provides the balance sheet for Zhengye Biotechnology Holding Ltd (ZYBT), offering detailed quarterly and annual financial data. It covers various financial components such as assets, liabilities, and shareholders' equity, alongside FAQs explaining key financial metrics and their relevance for investors. The information …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Zhengye Biotechnology Holding Ltd (ZYBT) Institutional Confidence

This article provides details on the institutional shareholding and shareholder activity for Zhengye Biotechnology Holding Ltd (ZYBT). It lists the top institutional holders and changes in their shares held, showing new or increased positions from several firms like XTX Markets LLC and Winton Capital …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Zhengye Biotechnology Holding Ltd (ZYBT) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Zhengye Biotechnology Holding Ltd (ZYBT), detailing various metrics related to volatility, financial risk, and investment risk. It includes data points such as maximum drawdown, realised volatility, downside risk-adjusted return, and liquidity measured by average turnover rate. The …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Zhengye Biotechnology Holding Ltd

This article provides a revenue breakdown for Zhengye Biotechnology Holding Ltd (ZYBT) for FY2024. The company's revenue is primarily derived from swine vaccines, which account for 84.67% of its total revenue, followed by poultry vaccines and other vaccines. All reported revenue originates solely from …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TradingKey

This page provides financial information for Zhengye Biotechnology Holding Ltd (ZYBT), focusing on its income statement. It includes historical revenue, net income, and operating profit for fiscal year 2025, along with FAQs explaining how to interpret income statements, differences between quarterly and annual reports, …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ZYBT|Zhengye Biotechnology Holding Ltd|Price:1.730|Chg%:-0.070

This article provides detailed financial and company information for Zhengye Biotechnology Holding Ltd (ZYBT), a company specializing in veterinary vaccine research, development, manufacturing, and sales. It includes current stock price, key figures, performance over various periods, technical indicators, company overview, and shareholder information. The …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Zhengye Biotechnology Holding Ltd (ZYBT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on the dividend and stock split history for Zhengye Biotechnology Holding Ltd (ZYBT). It states that the company has distributed a total of $0.00 in dividends over the past five years and currently shows no upcoming dividend data. The page …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Zhengye Biotechnology addresses unusual trading activity

Zhengye Biotechnology Holding Limited has released a statement acknowledging unusual trading activity in its Class A ordinary shares. The company states it is unaware of any material non-public information or corporate developments that would explain the surges in trading volume and price. Zhengye Biotechnology …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session

This article details 12 healthcare stocks experiencing notable movements in Thursday's pre-market session, categorized into gainers and losers. Key gainers include Niki BioSolutions, Zhengye Biotechnology, and Medpace Holdings, with some movements influenced by recent earnings reports. Conversely, China SXT Pharmaceuticals, Nuwellis, and Community Health …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Zhengye Biotechnology Stock Plunges Following 322% Rally In Volatile Reversal

Zhengye Biotechnology (NASDAQ: ZYBT) shares plummeted after an extreme volume-driven rally, with the company stating it is unaware of any undisclosed catalyst for the volatile price and volume movement. The stock had previously surged 322.6% but then saw a significant selloff, with shares down …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ZYBT Stock Whipsaws After Parabolic Spike Draws Day Traders

Zhengye Biotechnology Holding Limited (ZYBT) experienced a significant parabolic spike, rising from sub-$1 to over $8, followed by a sharp crash to $2.84, demonstrating classic low-float momentum behavior often seen with day traders. Despite strong balance sheet fundamentals, including $50M in cash and low …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Trending Stocks Today | Zhengye Biotechnology Shoots up 322.63%

This article focuses on the significant stock performance of Zhengye Biotechnology, which saw an impressive increase of 322.63% today. It highlights the company's substantial surge, positioning it as a trending stock. The content, however, is not available as it states "Document" as the article …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

12 Health Care Stocks Moving In Monday's Intraday Session

This article identifies 12 healthcare stocks that experienced significant price movement during Monday's intraday trading session. It highlights both gainers, such as Zhengye Biotechnology and Advanced Biomed, and losers, including Karyopharm Therapeutics and Pomdoctor, providing their percentage change and market capitalization. The movements were …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Day's Trending USA Stocks | Zhengye Biotechnology Holding Limited(ZYBT): Overnight gain 1047.6%

This article highlights Zhengye Biotechnology Holding Limited (ZYBT) as the top-gaining USA stock with an overnight surge of 1047.6%, driven by its low float, strong fundamentals in the animal vaccine sector, and rising investor sentiment. It also details the corporate profiles and recent performance …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ZYBT Stock Explodes Higher As Traders Pile Into Momentum

Zhengye Biotechnology Holding Limited (ZYBT) stock has surged by 146.42%, attracting significant attention from momentum traders. The company's financials show over $50M in cash against less than $10M in long-term debt, and its price-to-sales ratio is low, suggesting it's undervalued. Traders are focused on …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context